Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / H•••••• C•••••• M••••••••• L••

H•••••• C•••••• M••••••••• L••

Buyout firm · probableMiddle marketNew York, NYh•••••••••.comSEC registered investment adviser

H••••••™ is a New York City-based private equity investment firm focused on middle-market companies across the world of healthcare.

Classification
Class
Buyout firmprobable, confidence 80%
Basis
own website statement
Size band
Middle marketdefined by: proxy: $1.47bn Private Equity Fund GAV on the Form ADV filed 2024-03-29
Classification history (2)
  1. Sep 15, 2026
    Buyout firm (probable, 80%, cls-pe-2)
    own website statement
    H••••••™ is a New York City-based private equity investment firm focused on middle-market companies across the world of healthcare.
    hildred.com
  2. Sep 13, 2026
    Buyout firm (confirmed, 85%, cls-pe-1)
    R6: 11 of 11 distinct vehicles are sworn Private Equity Funds; 10 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
Adviser type
registered investment adviser
Form ADV filings
Apr 15, 2019 to Mar 29, 2024
RAUM
$1.5Bregulatory assets under management of the adviser; not dry powder, not a fund size
PE funds, latest filing
11
PE fund GAV, latest filing
$1.5Breported gross assets (Form ADV), not fund size
All private fund GAV
$1.5Bevery private fund type, latest filing
2024 PE fund GAV
$1.5Bsum over funds typed Private Equity Fund with a 2024 or later as-of date
PE share of funds, lifetime
100%
Fund type mix
filed 2024-03-29, latest gav Private Equity Fund $1.5B, latest counts Private Equity Fund 11, lifetime distinct Private Equity Fund 11
Employees
17
Headquarters
New York, NY
Office address
745 FIFTH AVENUE, SUITE 800, New York, NY, 10151-1706
Business phone
646-362-5965
Stated criteria beside observed behaviour
18 observed deals
Stated by the firm
Sectors
healthcare
Geography
not stated or not yet read
Revenue
up to $100M
EBITDA
not stated or not yet read
Enterprise value
not stated or not yet read
Equity check
not stated or not yet read
Control
not stated or not yet read
Thesis
We seek to back exceptional management teams in structurally attractive healthcare sectors that have sizeable market potential, excellent growth prospects, attractive innovation opportunities and manageable pricing trends and competition.
Observed from deals on record
roles
add on 4, unknown 12, platform 3
period
to 2024-04-30, from 2023-05-02, undated holdings 14, dated observations 10
window
last 2024-04-30, first 2023-05-02
control
control 4, unknown 15
companies
18
geography
count 1, share 0.056, value CT
investments
19
seller kinds
unknown 1
transactions
5
cadence by year
2023 add ons 2, other deals 1, 2024 add ons 2
platform add on
add ons 4, platforms 3, add ons per platform 1.33
sector known for
3
disclosed value usd
n 0
sector distribution
count 2, share 0.111, value healthcare services, examples Mountainside Wellness, SportsMed Physical Therapy, count 1, share 0.056, value healthcare it, examples Tebra
holding period years
n 0
repeat counterparties
role legal adviser, shared 3, entity id 518b747b-9ab8-44db-9ac4-9fbc3cddd863, role co investor, shared 2, entity id e0f036c1-39d2-4380-8078-7613eace12c9, role legal adviser, shared 2, entity id deb21b83-f5c0-4e2a-93eb-3c0ef69d004d
subsector distribution
count 2, share 0.111, value physical occupational therapy, examples Mountainside Wellness, SportsMed Physical Therapy, count 1, share 0.056, value healthcare it, examples Tebra

18 companies on the graph (5 transactions); most in healthcare services (2); 3 platforms and 4 add-ons; observed 2023 to 2024

Funds
11 on record
FundVehicleVintageReported gross assets (Form ADV), not fund sizeGAV by yearForm D soldLifecycle
H•••••• P•••••••• P••••••• I• L•
ADV: Private Equity Fund
buyout or unlabelled2024
first reported on Form ADV
$760M
as of Mar 29, 2024
no Form DUnknown
H•••••• C•••••• C••••••••• L•
ADV: Private Equity Fund
Co-investment vehicle2023
first reported on Form ADV
$24.7M
as of Mar 29, 2024
no Form DEarly deployment
H•••••• C•••••• C••••••••• L•
ADV: Private Equity Fund
Co-investment vehicle2022
first reported on Form ADV
$66.7M
as of Mar 29, 2024
no Form DEarly deployment
H•••••• E••••• P••••••• I••••• L•
ADV: Private Equity Fund
Buyout fund2022
first reported on Form ADV
$58.0M
as of Mar 29, 2024
no Form DUnknown
H•••••• C•••••• C••••••••• L•
ADV: Private Equity Fund
Co-investment vehicle2022
first reported on Form ADV
$41.4M
as of Mar 29, 2024
no Form DEarly deployment
H•••••• C•••••• C••••••••• L•
ADV: Private Equity Fund
Co-investment vehicle2021
first reported on Form ADV
$41.0M
as of Mar 29, 2024
no Form DUnknown
H•••••• C•••••• C••••••••• L•
ADV: Private Equity Fund
Co-investment vehicle2021
first reported on Form ADV
$0
as of Mar 29, 2024
no Form DUnknown
H•••••• E••••• P••••••• I•• L•
ADV: Private Equity Fund
buyout or unlabelled2019
first reported on Form ADV
$432M
as of Mar 29, 2024
no Form DMature
H•••••• E••••• P••••••• I•••• L•
ADV: Private Equity Fund
Buyout fund2019
first reported on Form ADV
$23.2M
as of Mar 29, 2024
no Form DMature
H•••••• E••••• A••••••••• I•• L•
ADV: Private Equity Fund
buyout or unlabelled2019
first reported on Form ADV
$9.7M
as of Mar 29, 2024
no Form DMature
H•• A••••••••• I• L••
ADV: Private Equity Fund
buyout or unlabelledunknown$11.9M
as of Mar 29, 2024
no Form DActive deployment
Team
37 current, 1 former
Managing partner (5)
Partner (5)
Vice president (7)
Platform (8)
1 former (kept with end dates)
Portfolio
19 relationships, 3 platforms, 4 add-ons
CompanyRoleStatusInvestedHeldPartnerSource
P•••••••Add-onactiveApr 30, 2024
transaction announcement
2.4 yearsunknownFact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
M••••••••• W•••••••Add-onactiveJan 9, 2024
transaction announcement
2.7 yearsunknownFact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
I•••••• U•• H•••••••• L••Add-onactiveOct 24, 2023
transaction announcement
2.9 yearsunknownFact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
M••••••••• W•••••••Add-onactiveOct 18, 2023
transaction announcement
2.9 yearsunknownFact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
A••••••••Role unknownactiveMay 2, 2023
transaction announcement
3.4 yearsA••••• G•••••• (confirmed)Fact Investment organization websites (team, portfolio, strategy, criteria, news)
B••• H•••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
B•••••••• N••••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
C••••• C••••••• H•••••PlatformactiveunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
C••••••• C•••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
D••••••• M•••••••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
H•••••••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
H••••••• N•••••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
i••••••••• H•••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
O•••••••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
P••••••••• I••••••••• I••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
R••••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
S••••••••PlatformactiveunknownunknownunknownFact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
S•••••••• P••••••• T••••••PlatformactiveunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
T••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
Transactions
5 on record
DateTypeTargetThis firm’s roleSource
Apr 30, 2024Add-on acquisitionP•••••••Sponsor (confirmed)hildred.com
Jan 9, 2024Add-on acquisitionM••••••••• W•••••••Sponsor (confirmed)hildred.com
Oct 24, 2023Add-on acquisitionI•••••• U•• H•••••••• L••Sponsor (confirmed)hildred.com
Oct 18, 2023Add-on acquisitionM••••••••• W•••••••Sponsor (confirmed)hildred.com
May 2, 2023Growth investmentA••••••••Sponsor (confirmed)hildred.com
Placement agents, lenders, advisers and co-investors
10 relationships
Placement agents (2)
  • M••••••• G••••• I••• 3 shared · strong · last Jan 1, 2022
  • E••••••• G•••• L••••• 1 shared · one time · last Jan 1, 2024
Lenders (1)
  • O••••• F•••••• 1 shared · one time · last Oct 18, 2023
Financial advisers (2)
  • S••••• 1 shared · one time · last Oct 24, 2023
  • L•••••• I••••••••• L•• 1 shared · one time · last Apr 30, 2024
Legal advisers (4)
  • H•••••• • K••••• 3 shared · strong · last Jan 9, 2024
  • S••••• A••••• L•• 2 shared · recurring · last Apr 30, 2024
  • K•• G••••• L•• 1 shared · one time · last May 2, 2023
  • K••••• L•• 1 shared · one time · last May 2, 2023
Co-investors (1)
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
25 most recent
  1. Apr 6, 2026
    H•••••• C•••••• M••••••••• L••: Private Equity Funds on Form ADV 11 (2024 extract) -> 17 (roster 2026-09-01)
  2. Oct 8, 2025
    A•••••••• Appoints Joseph Cosgrove as Chief Executive Officer and Member of the Board of Directors
  3. Feb 7, 2025
    Crown Laboratories Completes A••••••••• of R•••••• Therapeutics
  4. Dec 9, 2024
    Crown Laboratories and R•••••• Enter into Amended and Restated Merger Agreement
  5. Sep 16, 2024
    B•• S•••• Appointed Managing Director at H•••••• Capital Management
  6. Aug 12, 2024
    Crown Laboratories and R•••••• Announce Entry Into Merger Agreement
  7. Apr 30, 2024
    C••••• C••••••• H••••• Acquires Penetrex from Wellbeam C••••••• H•••••
  8. Feb 26, 2024
    W••• F•••• and S•••••• H••••••••• Appointed Partners at H•••••• Capital Management
  9. Jan 9, 2024
    S•••••••• P••••••• T•••••• Acquires Red Bank P••••••• T••••••
  10. Dec 19, 2023
    Hello Bello Secures Future Growth with Sale to H•••••• Capital Management
  11. Oct 24, 2023
    C••••• C••••••• H••••• Acquires I•••••• U•• H•••••••• L••
  12. Oct 18, 2023
    S•••••••• P••••••• T•••••• Acquires M••••••••• W•••••••
  13. Oct 11, 2023
    Fortune Magazine Names H••••••• N••••••• to 2023 Best Workplaces in Manufacturing & Production List
  14. May 2, 2023
    H•••••• Capital Management Completes S•••••••• Investment in A••••••••
  15. May 2, 2023
    H•••••• Capital Management Completes S•••••••• Investment in A••••••••
  16. Oct 20, 2022
    C••••• C••••••• H••••• names Scott Chapman Chief Executive Officer
  17. Jul 21, 2022
    H•••••• Capital Management Appoints O••• M•••••••• Managing Director and Chief Financial Officer
  18. Jul 12, 2022
    H•••••• Capital Management Promotes K•••• R•••• to Vice President
  19. May 24, 2022
    Crown Laboratories Expands Aesthetics' Portfolio With A••••••••• Of Eclipse Medcorp, Llc Assets
  20. Feb 22, 2022
    D••••••• M••••••••• Announces the A••••••••• of Multiple Dermatology Clinics
  21. Feb 15, 2022
    H•••••• Capital Management Closes H•••••• Equity Partners II Fund at $363 Million
  22. Aug 26, 2021
    Crown Laboratories to Acquire StriVectin®, the #1 Independent Prestige Skincare Company in the U.S.
  23. May 22, 2019
    Crown Laboratories Acquires Xycrobe™ Therapeutics, Inc., an Innovator in Skin Microbiome Technology
  24. Apr 15, 2019
    H•••••• C•••••• M••••••••• L•• first filed Form ADV in the extract (IA)
  25. Sep 27, 2018
    Crown Laboratories Acquires Bellus Medical
Across the graphs

H•••••• C•••••• M••••••••• L•• is the same institution as 2 records in Independent Sponsors and RIA and Wealth.

Independent Sponsors1RIA and Wealth1

Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.

Checking your plan…